Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Surface Oncology stock (SURF)

Buy Surface Oncology stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Surface Oncology is a biotechnology business based in the US. Surface Oncology shares (SURF) are listed on the NASDAQ and all prices are listed in US Dollars. Surface Oncology employs 35 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Surface Oncology stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Best for beginners

Go to site
Get up to $1,000 in stock
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for cash sweep

Go to site
Advanced charts and trading tools
  • Trade stocks, ETFs and equity options without commission and $0 option contract fees
  • Earn up to 8.1% APY on your uninvested cash
  • Get a 1.5% match in cash on transferred assets up to $300 or up to 15 free fractional shares worth between $2 and $2,000

How to buy Surface Oncology stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – SURF. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Surface Oncology stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $1,000 in stock
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Choose a 1.5% match or up to 15 free fractional shares
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Surface Oncology stock price (NASDAQ: SURF)

Use our graph to track the performance of SURF stocks over time.

Surface Oncology shares at a glance

Information last updated 2024-06-30.
Latest market close$1.07
52-week range$0.83 - $1.12
50-day moving average $0.95
200-day moving average $0.82
Wall St. target price$2.38
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.66

Is it a good time to buy Surface Oncology stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Surface Oncology price performance over time

Historical closes compared with the close of $1.07 from 2023-09-12

1 week (2024-07-01) N/A
1 month (2024-06-08) N/A
3 months (2024-04-08) N/A
6 months (2024-01-08) N/A
1 year (2023-07-12) 8.08%
2 years (2022-07-12) -44.56%
3 years (2021-07-12) 7.01
5 years (2019-07-12) 2.64

Surface Oncology financials

Gross profit TTM $-37,003,000
Return on assets TTM -41.42%
Return on equity TTM -105.78%
Profit margin 0%
Book value $0.81
Market Capitalization $65.7 million

TTM: trailing 12 months

Surface Oncology share dividends

We're not expecting Surface Oncology to pay a dividend over the next 12 months.

Surface Oncology share price volatility

Over the last 12 months, Surface Oncology's shares have ranged in value from as little as $0.827 up to $1.12. A popular way to gauge a stock's volatility is its "beta".

SURF.US volatility(beta: 1.75)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Surface Oncology's is 1.7527. This would suggest that Surface Oncology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Surface Oncology overview

Surface Oncology, Inc. , a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibody that inhibits CD39 enzymatic activity for the production of adenosine and the breakdown of adenosine triphosphate; SRF388 which is in phase II clinical trial targeting interleukin 27; GSK4381562, an antibody targeting CD112R, an inhibitory protein expressed on natural killer and T cells; and SRF114 that is in phase 1/2 clinical trials targeting the chemokine receptor CCR8. Surface Oncology, Inc. has a license agreement with GlaxoSmithKline Intellectual Property (No. 4) Limited and Vaccinex, Inc. to develop, manufacture, and commercialize antibodies, which targets SRF114.

Frequently asked questions

What percentage of Surface Oncology is owned by insiders or institutions?
Currently 7.277% of Surface Oncology shares are held by insiders and 46.033% by institutions.
How many people work for Surface Oncology?
Latest data suggests 35 work at Surface Oncology.
When does the fiscal year end for Surface Oncology?
Surface Oncology's fiscal year ends in December.
Where is Surface Oncology based?
Surface Oncology's address is: 50 Hampshire Street, Cambridge, MA, United States, 02139
What is Surface Oncology's ISIN number?
Surface Oncology's international securities identification number is: US86877M2098
What is Surface Oncology's CUSIP number?
Surface Oncology's Committee on Uniform Securities Identification Procedures number is: 86877M209

More guides on Finder

Ask a Question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site